Abnormalities of Aβ42 in CSF, PET Aβ/tau/brain atrophy, and impairment of brain metabolism and episodic memory appear 25, 15, and 10 years earlier than the expected symptoms of AD, respectively.125. Here, MAPT is linked to Alzheimer disease.